Successful Umbilical Cord Blood Transplantation With Reduced-intensity Conditioning for Acute Myeloid Leukemia in a Child With Shwachman-Diamond Syndrome.

Journal of Pediatric Hematology/oncology
Satoshi YoshimuraDaisuke Tomizawa

Abstract

Outcomes of patients with Shwachman-Diamond syndrome (SDS) who developed myeloid malignancies are poor because of refractory disease and high hematopoietic stem cell transplantation-related mortality. We herein report a case of a 7-year-old girl with SDS who developed acute myeloid leukemia with monosomy 7. She was successfully treated with chemotherapy followed by unrelated cord blood transplantation with reduced-intensity conditioning consisting of fludarabine, melphalan, and high-dose cytarabine without significant toxicity. Reduced-intensity conditioning presented in this report might be a preferable option for SDS patients with acute myeloid leukemia, although further evaluation in a larger number of similar cases is necessary.

References

Dec 1, 1993·Leukemia & Lymphoma·J F Seymour, S M Escudier
Aug 1, 1996·British Journal of Haematology·O P SmithP Milla
Nov 14, 1997·British Journal of Haematology·I DokalJ Goldman
Aug 31, 2002·Bone Marrow Transplantation·J W HsuR A Brodsky
Dec 11, 2002·British Journal of Haematology·Joan CunninghamNorman Pratt
Mar 10, 2004·International Journal of Hematology·Tetsuo MitsuiKiyoshi Hayasaka
Oct 4, 2005·British Journal of Haematology·Simone CesaroUNKNOWN EBMT Severe Aplastic Anaemia and Paediatric Diseases Working Party
Apr 12, 2012·Haematologica·Jean DonadieuUNKNOWN Associated investigators of the French Severe Chronic Neutropenia Registry*
May 4, 2018·JCI Insight·Elaine Coustan-SmithDario Campana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.